Comments
Loading...
Latest Amgen Stock News | NASDAQ:AMGN | Benzinga
Get the latest news on Amgen stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Amgen performance
Categories: All
Monday, April 14, 2025
Friday, April 11, 2025
Wednesday, April 09, 2025
Monday, April 07, 2025
Friday, April 04, 2025
- Vertex, Alnylam Best Positioned As Biopharma Braces For Tariff Impact, Goldman Sachs Flags Regeneron, Biogen Risks
- Nasdaq 100 Enters Bear Market, Dow In Correction Territory, Traders Await Fed Chair Powell's Remarks
- FDA Approves Amgen's Uplizna As First Drug For Chronic Immune-Mediated Fibroinflammatory Disorder
- Amgen, Sabra Health Care And A Financial Stock On CNBC's 'Final Trades'